Trial · NCT06160778
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain relief as measured on the verbal numerical rating scale | 60 minutes post drug administration | Between group mean differences in pain as measured on an 11-point verbal Numerical Rating Scale (0 is no pain and 10 is worst pain ever) |
| Secondary | Pain relief as measured on the verbal numerical rating scale | 30 minutes post drug administration | Between group mean differences in pain as measured on an 11-point verbal |
| Secondary | Pain relief as measured on the verbal numerical rating scale | 90 minutes post drug administration | Between group mean differences in pain as measured on an 11-point verbal |
| Secondary | Pain relief as measured on the verbal numerical rating scale | 120 minutes post drug administration | Between group mean differences in pain as measured on an 11-point verbal |
| Secondary | Pain relief as measured on the verbal numerical rating scale | 6 hours post drug administration | Between group mean differences in pain as measured on an 11-point verbal |
| Secondary | Pain relief as measured on the verbal numerical rating scale during the ultrasound diagnostic | up to 6 hours post drug administration | score from 0-10 on verbal numerical rating scale |
| Secondary | Proportion who achieve the minimal important difference for pain relief | 60 minutes post drug administration | Proportion of participants who achieves the 2-point verbal Numerical Rating Scale minimal important difference pain score reduction |
| Secondary | Proportion who achieve the minimal important difference for pain relief | 120 minutes post drug administration | Proportion of participants who achieves the 2-point verbal Numerical Rating Scale minimal important difference pain score reduction |
| Secondary | Change in baseline pain category | 30 minutes post drug administration | Proportion of participants who change the severity of their baseline pain category. Pain categories on the verbal numerical rating scale as follows: mild = 0 to 4, moderate = 5 to 7, severe \>7) |
| Secondary | Change in baseline pain category | 60 minutes post drug administration | Proportion of participants who change the severity of their baseline pain category. Pain categories on the verbal numerical rating scale as follows: mild = 0 to 4, moderate = 5 to 7, severe \>7) |
| Secondary | Change in baseline pain category | 90 minutes post drug administration | Proportion of participants who change the severity of their baseline pain category. Pain categories on the verbal numerical rating scale as follows: mild = 0 to 4, moderate = 5 to 7, severe \>7) |
| Secondary | Change in baseline pain category | 120 minutes post drug administration | Proportion of participants who change the severity of their baseline pain category. Pain categories on the verbal numerical rating scale as follows: mild = 0 to 4, moderate = 5 to 7, severe \>7) |
| Secondary | Change in baseline pain category | 6 hours post drug administration | Proportion of participants who change the severity of their baseline pain category. Pain categories on the verbal numerical rating scale as follows: mild = 0 to 4, moderate = 5 to 7, severe \>7) |
| Secondary | Time to effective analgesia | up to 6 hours post drug administration | Duration of time from time of drug administration to time at which a verbal Numerical Rating Scale ≤3 is achieved. |
| Secondary | Additional analgesia requirment | up to 6 hours post drug administration | Proportion of participants requiring any additional analgesia in each trial arm |
| Secondary | Total opioids administered | up to 8 hours post drug administration | total morphine-equivalent mg/kg administered for all trial participants |
| Secondary | Ramsay sedation score | 30 minutes post drug administration | Assessment of sedation levels post drug administration; score is 1-6 (1 is alert, 6 is not responsive) |
| Secondary | Ramsay sedation score | 60 minutes post drug administration | Assessment of sedation levels post drug administration; score is 1-6 (1 is alert, 6 is not responsive) |
| Secondary | Ramsay sedation score | 90 minutes post drug administration | Assessment of sedation levels post drug administration; score is 1-6 (1 is alert, 6 is not responsive) |
| Secondary | Ramsay sedation score | 120 minutes post drug administration | Assessment of sedation levels post drug administration; score is 1-6 (1 is alert, 6 is not responsive) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06160778/registered